[
  {
    "ts": "2025-05-02T13:33:42+00:00",
    "headline": "West Pharmaceutical Services (WST) Fell on Disappointing Guidance",
    "summary": "Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the fund’s Investor Class fund ARTMX returned -7.40%, Advisor Class fund APDMX posted a return of -7.37%, and Institutional Class fund APHMX returned -7.35%, compared […]",
    "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-fell-133342689.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6d9aab78-c1aa-340d-b465-b42e40419b10",
      "content": {
        "id": "6d9aab78-c1aa-340d-b465-b42e40419b10",
        "contentType": "STORY",
        "title": "West Pharmaceutical Services (WST) Fell on Disappointing Guidance",
        "description": "",
        "summary": "Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter, the fund’s Investor Class fund ARTMX returned -7.40%, Advisor Class fund APDMX posted a return of -7.37%, and Institutional Class fund APHMX returned -7.35%, compared […]",
        "pubDate": "2025-05-02T13:33:42Z",
        "displayTime": "2025-05-02T13:33:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3da65c788695754bfdb5c982fc3e065c",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "West Pharmaceutical Services, Inc. (WST): One of the Low Profile Dividend Champions to Buy",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PGr9HSGyEBZ0qk1Tzaju6w--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3da65c788695754bfdb5c982fc3e065c.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OUOi2LvoJ_pBGZws_4e16A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3da65c788695754bfdb5c982fc3e065c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-fell-133342689.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/west-pharmaceutical-services-wst-fell-133342689.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]